Comprehensive SRS Regenerex Tissue Attachment
← catalyst calendarNCT06615739 · readout in 134 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
22actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-10-22 | actual | When the study began enrolling |
| Primary completion | 2026-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2024-09-27 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-10-29 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Arthroplasty Complications
- Osteo Arthritis Shoulders
Intervention
- Device: Regenerex Tissue Attachment Augments
Primary outcomes
what the primary-completion date above is the date OFKaplan Meier Implant Survivorship
measured Up to 10 Years
Safety Assessement
measured Up to 10 Years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed